Philips Wearable Biosensor
Friday, Royal Philips said that it has received Food and Drug Administration clearance for IntelliVue Guardian, a monitoring system that detects subtle signs of impending health issues for hospitalized patients. The 510(k) clearance allows the global company to pair IntelliVue Guardian with the single-use, adhesive Philips Wearable Sensor in the U.S.
The software acquired CE Mark certification for sale in Europe in October.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“This little biosensor is the gap filler” that facilitates continuous monitoring of heart rate and respiration in high-acuity patients, said Dr. Kevin Dellsperger, CMO of Augusta (Georgia) University Health. Dellsperger was one of several participants in a Philips-sponsored breakfast discussion Monday at the annual Healthcare Information and Management Systems Society conference in Orlando, Florida.
In a pilot at Augusta University Medical Center, IntelliVue Guardian regularly was able to head off cardiac arrest and found an 88 percent reduction in “predictable” codes, Dellsperger reported.
“We found that 4-6 hours before someone arrested, there was a change in their vital signs,” Dellsperger, a cardiologist, said. “That change can be so subtle that residents miss it.” Sometimes, even attending physicians miss it, too.
This was but one of several pieces of news the Amsterdam-based technology company discussed Monday at HIMSS17.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Philips unveiled IntelliSpace Enterprise Edition, which the vendor called the first hospital-wide informatics managed service. It essentially bundles various informatics functions into a pay-per-use package.
Another new flavor, IntelliSpace Genomics, delivers genomic data along with patient records, test results and medical images to the point of care. This will complement Illumeo, a next-generation sequencing platform the company debuted at the Radiological Society of North American scientific meeting in late November.
“This is sequencing at a massive scale,” Sanjay Chikarmane, general manager of enterprise informatics at DNA sequencing giant Illumina. Philips and Illumina last month entered into a strategic partnership to match sequencing and informatics technologies.
“We are bringing together our imaging devices with our analytics platform” to assist in the practice of precision medicine, Philips Connected Care & Health Informatics CEO Jeroen Tas said at the press conference.
In one consumer move on Monday, the health tech company unveiled a mobile app called Jovia Coach to help healthcare systems reach out to patients at risk for Type 2 diabetes. “If we track adherence [to population health programs], we might as well coach patients and we might as well connect them to their caregivers,” Tas said.
Photo: Philips
